Cargando…

Acquisition of aneuploidy drives mutant p53-associated gain-of-function phenotypes

p53 is mutated in over half of human cancers. In addition to losing wild-type (WT) tumor-suppressive function, mutant p53 proteins are proposed to acquire gain-of-function (GOF) activity, leading to novel oncogenic phenotypes. To study mutant p53 GOF mechanisms and phenotypes, we genetically enginee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Redman-Rivera, Lindsay N., Shaver, Timothy M., Jin, Hailing, Marshall, Clayton B., Schafer, Johanna M., Sheng, Quanhu, Hongo, Rachel A., Beckermann, Kathryn E., Wheeler, Ferrin C., Lehmann, Brian D., Pietenpol, Jennifer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408227/ https://www.ncbi.nlm.nih.gov/pubmed/34465782 http://dx.doi.org/10.1038/s41467-021-25359-z

Ejemplares similares

Detection of internal exon deletion with exon Del
por: Guo, Yan, et al.
Publicado: (2014)

Regulators of Oncogenic Mutant TP53 Gain of Function
por: Yamamoto, Satomi, et al.
Publicado: (2018)

Gain-of-function mutant p53: history and speculation
por: Bargonetti, Jill, et al.
Publicado: (2019)

p73 Is Required for Ovarian Follicle Development and Regulates a Gene Network Involved in Cell-to-Cell Adhesion
por: Santos Guasch, Gabriela L., et al.
Publicado: (2018)

On the role of p53 in the cellular response to aneuploidy
por: Narkar, Akshay, et al.
Publicado: (2021)

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53
por: Donzelli, Sara, et al.
Publicado: (2008)

Selective targeting of p53 gain-of-function mutants in cancer
por: Padmanabhan, Achuth
Publicado: (2018)

Gain-of-function mutant p53 in cancer progression and therapy
por: Zhang, Cen, et al.
Publicado: (2020)

Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53
por: Vikhanskaya, Faina, et al.
Publicado: (2007)

Gain of function of mutant p53: R282W on the peak?
por: Zhang, Y, et al.
Publicado: (2016)

Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target
por: Schulz-Heddergott, Ramona, et al.
Publicado: (2018)

Context is everything: extrinsic signalling and gain-of-function p53 mutants
por: Amelio, Ivano, et al.
Publicado: (2020)

Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis
por: Stein, Yan, et al.
Publicado: (2019)

Corrigendum to “Comparative Study of Exome Copy Number Variation Estimation Tools Using Array Comparative Genomic Hybridization as Control”
por: Guo, Yan, et al.
Publicado: (2017)

Editor's Note on ‘Cancer-derived p53 mutants suppress p53-target gene expression—potential mechanism for gain of function of mutant p53’
Publicado: (2023)

RNAseq by Total RNA Library Identifies Additional RNAs Compared to Poly(A) RNA Library
por: Guo, Yan, et al.
Publicado: (2015)

Permission to pass: on the role of p53 as a gatekeeper for aneuploidy
por: Marques, Joana F., et al.
Publicado: (2023)

Cytoplasmic gain-of-function mutant p53 contributes to inflammation-associated cancer
por: Bellazzo, Arianna, et al.
Publicado: (2015)

Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
por: Pedrote, Murilo M., et al.
Publicado: (2020)

Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer
por: Madrigal, Tzitzijanik, et al.
Publicado: (2021)

P53 Gain-of-Function Mutants and Steroids in Ovarian Cancer Cell Metastasis
por: Candelaria, Nicholes, et al.
Publicado: (2021)

Differential chromatin accessibility landscape of gain-of-function mutant p53 tumours
por: Dhaka, Bhavya, et al.
Publicado: (2021)

Gain of Function (GOF) Mutant p53 in Cancer—Current Therapeutic Approaches
por: Roszkowska, Katarzyna A., et al.
Publicado: (2022)

Impairment of rigidity sensing caused by mutant TP53 gain of function in osteosarcoma
por: Luo, Ming, et al.
Publicado: (2023)

Acquisition of Aneuploidy Provides Increased Fitness during the Evolution of Antifungal Drug Resistance
por: Selmecki, Anna M., et al.
Publicado: (2009)

Acquisition of cross-azole tolerance and aneuploidy in Candida albicans strains evolved to posaconazole
por: Kukurudz, Rebekah J, et al.
Publicado: (2022)

p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

Regulation of Nucleotide Metabolism by Mutant p53 Contributes to its Gain-of-Function Activities
por: Kollareddy, Madhusudhan, et al.
Publicado: (2015)

Control of Nucleotide Metabolism Enables Mutant p53’s Oncogenic Gain-of-Function Activity
por: Schmidt, Valentina, et al.
Publicado: (2017)

Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches
por: Alvarado-Ortiz, Eduardo, et al.
Publicado: (2021)

The Gain of Function of p53 Mutant p53S in Promoting Tumorigenesis by Cross-talking with H-RasV12
por: Jia, Shuting, et al.
Publicado: (2012)

p73 regulates epidermal wound healing and induced keratinocyte programming
por: Beeler, J. Scott, et al.
Publicado: (2019)

Aneuploidy tolerance caused by BRG1 loss allows chromosome gains and recovery of fitness
por: Schiavoni, Federica, et al.
Publicado: (2022)

Wild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a “dominant-positive” mechanism
por: Walerych, Dawid, et al.
Publicado: (2018)

Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
por: Zheng, Tongsen, et al.
Publicado: (2013)

Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities
por: Iyer, Swathi V., et al.
Publicado: (2015)

microRNAs: short non-coding bullets of gain of function mutant p53 proteins
por: Donzelli, Sara, et al.
Publicado: (2014)

Mutant p53 gain of function induces HER2 over-expression in cancer cells
por: Román-Rosales, A. A., et al.
Publicado: (2018)

Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo
por: Jung, Chae Lim, et al.
Publicado: (2016)

Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome
por: Zhang, Yao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ff896438l47stb8mt61qoc1q64